Posts by Carlos A. Camargo Jr., MD, DrPH
-
Acid Suppressant Therapy in Infancy Linked to Increased Risk of Childhood Respiratory Conditions
Lacey B. Robinson, MD, MPH, Carlos A. Camargo, Jr., MD, DrPH, and colleagues studied children with a history of severe bronchiolitis who were treated with acid suppressant medications during infancy, finding their risk of developing recurrent wheeze and asthma in early childhood was nearly doubled.
-
Prevalence of Anaphylaxis Increasing in U.S. Infants and Toddlers
Massachusetts General Hospital researchers, Lacey B. Robinson, MD, MPH, and Carlos A. Camargo, Jr., MD, DrPH, found that between 2006 and 2015 in the U.S., emergency department visits for anaphylaxis in infants and toddlers more than doubled while hospitalizations declined.
Biography
Dr. Carlos Arturo Camargo Jr., MD, DrPH, received his medical degree from the University of California, San Francisco; his Master of Public Health from the University of California, Berkeley; and his Doctor of Public Health from Harvard University. Dr. Camargo completed his residency at Massachusetts General Hospital, and research fellowship at Brigham & Women's Hospital. Currently, Dr. Camargo is Professor of Emergency Medicine and Medicine at Harvard Medical School and Professor of Epidemiology at Harvard T.H. Chan School of Public Health. He is founder and director of the Emergency Medicine Network (EMNet), a multidisciplinary collaboration that aims to advance public health through diverse projects in emergency care, particularly multicenter clinical research. Dr. Camargo also focuses on research training and mentorship. He received the Barger Excellence in Mentoring Award (2011) from Harvard Medical School, and the Potts Faculty Mentoring Award (2019) from Mass General. In 2016, he was honored by the American College of Emergency Physician’s Outstanding Contribution in Research Award.
Rheumatology, Allergy and Immunology
The Division of Rheumatology, Allergy and Immunology at Massachusetts General Hospital provides leading-edge treatment and transformative care to patients with rheumatic disease and autoimmune conditions.